Patents by Inventor Paul Touw

Paul Touw has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10586190
    Abstract: A request is received to book a flight on a private aircraft. A disruption cost associated with adding the flight to a previously optimized schedule of previously booked flights is determined. A price to be quoted to book the requested flight is computed based at least in part on the disruption cost.
    Type: Grant
    Filed: March 3, 2017
    Date of Patent: March 10, 2020
    Assignee: Stellar Labs, Inc.
    Inventors: David Fox, Christos Katsis, Lawrence E. Doxsee, Jr., Nicoleta Neagu, Paul Touw, Gary Waldman
  • Publication number: 20180101802
    Abstract: A request is received to book a flight on a private aircraft. A disruption cost associated with adding the flight to a previously optimized schedule of previously booked flights is determined. A price to be quoted to book the requested flight is computed based at least in part on the disruption cost.
    Type: Application
    Filed: March 3, 2017
    Publication date: April 12, 2018
    Inventors: David Fox, Christos Katsis, Lawrence E. Doxsee, JR., Nicoleta Neagu, Paul Touw, Gary Waldman
  • Publication number: 20100233690
    Abstract: The invention relates to the use of inhibitors of the expressed proteins of the murine genes and/or their human homologues listed in Table 1 for the preparation of a therapeutical composition for the treatment of cancer, in particular for the treatment of solid tumors of lung, colon, breast, prostate, ovarian, pancreas and leukemia and the use of the genes listed in Table 1 for the diagnosis of cancer. The invention also relates to the therapeutical compositions comprising the inhibitors and to methods for development of the inhibitor compounds.
    Type: Application
    Filed: October 28, 2009
    Publication date: September 16, 2010
    Applicant: Erasmus University Medical Center
    Inventors: Ivo Paul Touw, Hendrik Rudolf Delwel
  • Publication number: 20100003677
    Abstract: The present invention comprises a method method to identify tumor suppressor genes by detecting genes in a mouse retroviral insertion mutagenesis model which expression is inhibited by methylation of the viral insertion or the VIS-flanking gene. This is preferably accomplished by first randomly cutting the mouse genomic DNA, immunoprecipitating the methylated DNA and amplifying the VIS-flanking DNA by inverse PCR, optionally followed by cloning and sequencing of the amplicons. Next to the already known tumor suppressor genes Smad1 and Mad1-like, several putative tumor suppressor genes have been found. The tumor suppressing properties of these genes, as indicated in Table 3 also form part of the present invention. Further use of these genes and/or its substrates or downstream products, for diagnosis and therapy of cancer, preferably AML is envisaged.
    Type: Application
    Filed: June 1, 2006
    Publication date: January 7, 2010
    Applicant: ERASMUS UNIVERSITY MEDICAL CENTER ROTTERDAM
    Inventors: Ivo Paul Touw, Stefanus Joseph Erkeland, Renee Beekman